Johnson & Johnson announces advance purchase agreement with the African Vaccine Acquisition Trust

Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) (the Company), has entered into an agreement with the African Vaccine Acquisition Trust (AVAT) to make available up to 220 million doses of its single-shot COVID-19 vaccine candidate to African Union's 55 member states with delivery beginning in the third quarter of 2021.

from Breaking World Pharma News https://ift.tt/2PBIGF2